INSMED INC Increase (Decrease) in Accrued Liabilities
INSMED INC (INSM) reported Increase (Decrease) in Accrued Liabilities of $922.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2013-03-18
- INSMED INC increase (decrease) in accrued liabilities for the quarter ending 2012-12-31 was $891.00K, a 140.16% increase year-over-year.
- INSMED INC increase (decrease) in accrued liabilities for the quarter ending 2012-09-30 was -$1.05M, a 477.98% decline year-over-year.
- INSMED INC increase (decrease) in accrued liabilities for the quarter ending 2011-12-31 was $371.00K.
- INSMED INC increase (decrease) in accrued liabilities for the quarter ending 2011-09-30 was $277.00K, a 191.58% increase year-over-year.
- INSMED INC increase (decrease) in accrued liabilities for fiscal 2012 was $922.00K, a 38.23% increase from fiscal 2011.
- INSMED INC increase (decrease) in accrued liabilities for fiscal 2011 was $667.00K.
- INSMED INC increase (decrease) in accrued liabilities for fiscal 2010 was -$1.13M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2012-12-31 | $891.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$156.00K derived: sum of 2 quarters · filed 2013-03-18 | $922.00K 10-K · filed 2013-03-18 | ||
| 2012-09-30 | -$1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $31.00K 10-Q · filed 2012-11-07 | |||
| 2012-06-30 | $1.08M 10-Q · filed 2012-08-07 | ||||
| 2011-12-31 | $371.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $648.00K derived: sum of 2 quarters · filed 2013-03-18 | $667.00K 10-K · filed 2013-03-18 | ||
| 2011-09-30 | $277.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $296.00K 10-Q · filed 2012-11-07 | |||
| 2011-06-30 | $19.00K 10-Q · filed 2012-08-07 | -$94.00K 10-Q/A · filed 2011-08-08 | |||
| 2010-12-31 | -$1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$932.00K derived: sum of 2 quarters · filed 2013-03-18 | -$1.13M 10-K · filed 2013-03-18 | ||
| 2010-09-30 | $95.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-09 | -$100.00K 10-Q · filed 2011-11-09 | |||
| 2010-06-30 | -$195.00K 10-Q/A · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |